Figure 7.

Relative risk of overall malignancies in patients with rheumatoid arthritis (RA) compared with the general population. *Excluding non-melanoma skin; ^†all solid tumors; ^‡excluding lymphatic and hematopoetic. CI, confidence interval; DMARDs, disease-modifying antirheumatic drugs; MTX, methotrexate; n, number of malignancies; N, population size; SIR, standardized incidence ratio; TNF, tumor necrosis factor.